Possible Link between Serotonin and Interleukin 18 on Suicidality in Patients with Acute Coronary Syndrome
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: We investigated effects of serum serotonin and interleukin 18 levels on suicidal ideation (SI) at acute and chronic phases of acute coronary syndrome (ACS). Methods: Recent-onset 969 ACS patients were evaluated for serum serotonin and interleukin 18 levels; and SI by the “suicidal thoughts” item of the Montgomery–Åsberg Depression Rating Scale. After 1-year, 711 patients were re-evaluated for SI. Logistic regression models were used adjustment for potential covariates. Results: Associations between serum interleukin 18 and SI at both phases were significant only in the lower serotonin group. Conclusion: By evaluating serum serotonin and interleukin 18 levels, the clinical prediction of SI of ACS may be improved.
Abstract
Objective: We investigated effects of serum serotonin and interleukin 18 levels on suicidal ideation (SI) at acute and chronic phases of acute coronary syndrome (ACS). Methods: Recent-onset 969 ACS patients were evaluated for serum serotonin and interleukin 18 levels; and SI by the “suicidal thoughts” item of the Montgomery–Åsberg Depression Rating Scale. After 1-year, 711 patients were re-evaluated for SI. Logistic regression models were used adjustment for potential covariates. Results: Associations between serum interleukin 18 and SI at both phases were significant only in the lower serotonin group. Conclusion: By evaluating serum serotonin and interleukin 18 levels, the clinical prediction of SI of ACS may be improved.
참고문헌 (24)
- Virani SS, "American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2020 update : a report from the American Heart Association", Circulation, 141, pp.e139~e596 (2020)
- Larsen KK, "Myocardial infarction and risk of suicide : a populationbased case-control study", Circulation, 122, pp.2388~2393 (2010)
- Kim JM, "Determinants and escitalopram treatment effects on suicidal ideation in patients with acute coronary syndrome : findings from the K-DEPACS and EsDEPACS studies", Int J Cardiol, 219, pp.225~230 (2016)
- Hyun-Ju Yang, "The Moderating Effects of Accurate Expectations of Lethality in the Relationships between Suicide Intent and Medical Lethality on Suicide Attempts", Clinical Psychopharmacology and Neuroscience, 20(1), pp.180~184 (2022), 대한정신약물학회[DOI]
- Smith EG, "Suicide risk assessment received prior to suicide death by Veterans Health Administration patients with a history of depression", J Clin Psychiatry, 74, pp.226~232 (2013)
- Oquendo MA, "Toward a biosignature for suicide", Am J Psychiatry, 171, pp.1259~1277 (2014)
- Alessandro Serretti, "Clinical Utility of Fluid Biomarker in Depressive Disorder", Clinical Psychopharmacology and Neuroscience, 20(4), pp.585~591 (2022), 대한정신약물학회[DOI]
- Mann JJ, "The serotonergic system in mood disorders and suicidal behaviour", Philos Trans R Soc Lond B Biol Sci, 368(1615), pp.20120537~ (2013)
- Tyano S, "Plasma serotonin levels and suicidal behavior in adolescents", Eur Neuropsychopharmacol, 16, pp.49~57 (2006)
- Black C, "Meta-analysis of cytokines and chemokines in suicidality : distinguishing suicidal versus nonsuicidal patients", Biol Psychiatry, 78, pp.28~37 (2015)
- Kang HJ, "Relationship between interleukin-1β and depressive disorder after acute coronary syndrome", Prog Neuropsychopharmacol Biol Psychiatry, 72, pp.55~59 (2017)
- Kim JM, "Depression following acute coronary syndrome : time-specific interactions between stressful life events, social support deficits, and 5-HTTLPR", Psychother Psychosom, 86, pp.62~64 (2017)
- Karina Teixeira Magalhães-Guedes, "Psychobiotic Therapy: Method to Reinforce the Immune System", Clinical Psychopharmacology and Neuroscience, 20(1), pp.17~25 (2022), 대한정신약물학회[DOI]
- Herr N, "The effects of serotonin in immune cells", Front Cardiovasc Med, 4, pp.48~ (2017)
- Zhu CB, "The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters", Neuropsychopharmacology, 31, pp.2121~2131 (2006)
- 김재민, "Design and Methodology for the Korean Observational and Escitalopram Treatment Studies of Depression in Acute Coronary Syndrome: K-DEPACS and EsDEPACS", PSYCHIATRY INVESTIGATION, 11(1), pp.89~94 (2014), 대한신경정신의학회
- Montgomery SA, "A new depression scale designed to be sensitive to change", Br J Psychiatry, 134, pp.382~389 (1979)
- Santos CO, "A study of suicidal thoughts in acute stroke patients", J Stroke Cerebrovasc Dis, 21, pp.749~754 (2012)
- Murrough JW, "Ketamine for rapid reduction of suicidal ideation : a randomized controlled trial", Psychol Med, 45, pp.3571~3580 (2015)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (1994), American Psychiatric Association
- Killip T 3rd, "Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients", Am J Cardiol, 20, pp.457~464 (1967)
- Wonsuk Choi, "Associations of Serum Serotonin Levels with 12-week and 12-month Remission in Patients with Depressive Disorders", Clinical Psychopharmacology and Neuroscience, 20(2), pp.248~258 (2022), 대한정신약물학회[DOI]
- Mann JJ, "Neurobiology of suicidal behaviour", Nat Rev Neurosci, 4, pp.819~828 (2003)
- Yasuda K, "Interleukin-18 in health and disease", Int J Mol Sci, 20, pp.649~ (2019)
